Document is current
Any future updates will be listed below
-
Authors
Bulgarelli, Jenny
Piccinini, Claudia https://orcid.org/0000-0001-5862-6207
Scarpi, Emanuela
Gentili, Giorgia
Renzi, Laura
Carloni, Silvia
Limarzi, Francesco
Pancisi, Elena
Granato, Anna Maria
Petrini, Massimiliano
De Rosa, Francesco
Guidoboni, Massimo
Fanelli, Dalila
Tumedei, Maria Maddalena
Tazzari, Marcella
Baravelli, Stefano
Bronico, Ilaria
Cortesi, Pietro
Pignatta, Sara
Capelli, Laura
Ancarani, Valentina
Foschi, Giovanni
Turci, Livia
Tauceri, Francesca
Framarini, Massimo
Ridolfi, Laura
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02718391 at ClinicalTrials.govDocuments that mention this clinical trial
Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trial
https://doi.org/10.1186/s12967-025-06403-8
-
Funding
Funding for this research was provided by:
Ministero della Salute (PNC-E3-2022-23683269 PNC-LSH-TA)
- License Information
-
More Information
Article History
Received: 28 January 2025
Accepted: 19 March 2025
First Online: 18 April 2025
Declarations
:
: The protocol was approved by the institutional Medical Ethical Review Board CEIIAV Ethics Committee (approval n° 1231 of 30/07/2015) and the study was conducted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and later versions.
: All participants involved in the study have provided written informed consent for the publication of their data and images in this manuscript. All authors have reviewed the manuscript and provided their consent for its publication.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
